v-Myb Activators
The chemicals listed above can potentially activate v-Myb or influence the related signaling pathways. Azacitidine activates v-Myb by inhibiting DNA methylation, leading to demethylation of the v-Myb promoter region and increased expression of v-Myb. Flavopiridol indirectly activates v-Myb by inhibiting CDKs, which prevents the phosphorylation of v-Myb and enhances its transcriptional activity. Forskolin activates v-Myb through the cAMP signaling pathway, stimulating protein kinase A (PKA) and enhancing v-Myb transcriptional activity. PMA activates v-Myb by stimulating PKC signaling, leading to v-Myb phosphorylation and enhanced transcriptional activity. Trichostatin A activates v-Myb by inhibiting HDAC and promoting histone acetylation, resulting in increased v-Myb gene expression and downstream pathway activation.
In summary, these chemicals, collectively referred to as "v-Myb Activators," can activate v-Myb by modulating DNA methylation, inhibiting CDKs, stimulating cAMP signaling, activating PKC, and inhibiting HDAC. The activation of v-Myb by these chemicals can potentially enhance v-Myb transcriptional activity and downstream pathway activation, influencing various cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Azacitidine, a nucleoside analogue, can potentially activate v-Myb by inhibiting DNA methylation. It functions as a DNA methyltransferase inhibitor, leading to demethylation of the v-Myb promoter region. The demethylation of the promoter region allows for increased expression of v-Myb, leading to enhanced activation of downstream pathways associated with v-Myb. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol, a synthetic flavone derivative, can indirectly activate v-Myb by inhibiting cyclin-dependent kinases (CDKs). By inhibiting CDKs, flavopiridol prevents the phosphorylation of v-Myb and enhances its transcriptional activity. This leads to increased expression of target genes regulated by v-Myb, resulting in enhanced activation of cellular processes associated with v-Myb. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, a natural compound found in the Indian plant Coleus forskohlii, can activate v-Myb by stimulating the cAMP signaling pathway. Forskolin activates adenylate cyclase, leading to increased levels of intracellular cAMP. Elevated cAMP levels activate protein kinase A (PKA), which in turn phosphorylates and activates v-Myb. This results in enhanced transcriptional activity of v-Myb and subsequent activation of target genes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, a synthetic analog of phorbol ester, can activate v-Myb by stimulating protein kinase C (PKC) signaling. PMA activates PKC, which phosphorylates and activates v-Myb. The activated v-Myb then enhances the transcriptional activity of target genes, leading to the activation of cellular processes associated with v-Myb. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a potent histone deacetylase (HDAC) inhibitor, can potentially activate v-Myb by promoting histone acetylation. By inhibiting HDAC, trichostatin A increases histone acetylation at the v-Myb promoter region, leading to enhanced gene expression of v-Myb. This results in increased activation of downstream pathways regulated by v-Myb, influencing various cellular processes. | ||||||